المؤلفون: Naseerah Hassan MD, Elise Schapkaitz PhD, Haroun Rhemtula MD, FCOG, MMED, Nolukholo Ncete MD, FCPATH, MMED

المصدر: Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)

مصطلحات موضوعية: Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1938-2723

URL الوصول: https://doaj.org/article/f51f09bba9834a458e32678700ec97e7

المؤلفون: Ademi Z; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Switzerland, and Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia., Pfeil AM; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Switzerland., Hancock E; PHMR, London, United Kingdom., Trueman D; Source HEOR, Oxford, United Kingdom., Haroun RH; Novartis Pharma AG, Basel, Switzerland., Deschaseaux C; Novartis Pharma AG, Basel, Switzerland., Schwenkglenks M; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Switzerland.

المصدر: Swiss medical weekly [Swiss Med Wkly] 2017 Nov 15; Vol. 147, pp. w14533. Date of Electronic Publication: 2017 Nov 15 (Print Publication: 2017).

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Trägerverein Swiss Medical Weekly SMW Country of Publication: Switzerland NLM ID: 100970884 Publication Model: eCollection Cited Medium: Internet ISSN: 1424-3997 (Electronic) Linking ISSN: 00367672 NLM ISO Abbreviation: Swiss Med Wkly Subsets: MEDLINE

مواضيع طبية MeSH: Cost-Benefit Analysis*, Aminobutyrates/*therapeutic use , Angiotensin Receptor Antagonists/*therapeutic use , Antihypertensive Agents/*therapeutic use , Heart Failure/*drug therapy , Tetrazoles/*therapeutic use , Valsartan/*therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Biphenyl Compounds ; Chronic Disease ; Drug Combinations ; Enalapril/economics ; Enalapril/therapeutic use ; Female ; Heart Failure/physiopathology ; Hospitalization/economics ; Humans ; Male ; Middle Aged ; Quality-Adjusted Life Years ; Stroke Volume/physiology ; Switzerland ; Valsartan/economics

المؤلفون: Saeed CR; Department of Haematology, University of Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital and National Health Laboratory Service (NHLS), Johannesburg, South Africa. rufaro.chitsike@gmail.com, Jacobson BF, Pravin M, Aziz RH, Serasheini M, Dominique TG

المصدر: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2011 Aug; Vol. 17 (4), pp. 313-9. Date of Electronic Publication: 2010 Jun 13.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 9508125 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-2723 (Electronic) Linking ISSN: 10760296 NLM ISO Abbreviation: Clin Appl Thromb Hemost Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulants/*therapeutic use , Enoxaparin/*therapeutic use , Heart Valve Prosthesis/*adverse effects , Pregnancy Complications, Cardiovascular/*prevention & control , Thromboembolism/*prevention & control, Adolescent ; Adult ; Female ; Heart Valve Diseases/therapy ; Humans ; Pregnancy ; Pregnancy Complications, Cardiovascular/etiology ; Prospective Studies ; Thromboembolism/etiology ; Young Adult